Harmony Biosciences Holdings, Inc.

HRMY · Healthcare · Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for pati…

Harmony Biosciences Holdings, Inc. (HRMY), in the Healthcare sector, has 7 disclosed filings on Paydirt over the trailing twelve months from 3 corporate insiders: 0 purchases and 7 sales, 1 filed past the deadline. Filers took a median of 4 days from execution to disclosure, and the most recent trade was executed Sep 18 and filed Sep 18. The most active filer was Jeffrey Dierks with 8 filings.

Add to watchlist

Filings, ttm

0 buys · 7 sells · 1 late

Traders, ttm

3 insiders

Volume, ttmiDollar value disclosed in the window

$5.8M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Sep 18

Filed Sep 18

ADViAverage daily dollar volume

$34.7M

market data

Share price · 12M

$42.02 (+29.6%)

Adjusted for splits and dividends.

Volume by month

Buys $0 Sells $293.3M

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

Jeffrey Dierks CHIEF COMMERCIAL OFFICER 8 filings SK

Sandip Kapadia CHIEF FINANCIAL OFFICER 7 filings KB

Kumar Budur CHIEF MEDICAL OFFICER 2 filings JD

Jeffrey M. Dayno PRESIDENT, CEO 2 filings MI Marshman Fund Trust II 10% owner 1 filing JS

Juan A. Sabater Director 1 filing

Recent filings

Kumar BudurSALE CHIEF MEDICAL OFFICER $1.5M
35,852 sh × $43.05
Exec Sep 18
Filed Sep 18 · 4:48 PM ET Kumar BudurSALE CHIEF MEDICAL OFFICER $1.4M
32,954 sh across 3 lots
Exec Sep 4
Filed Sep 9 · 5:12 PM ET Sandip KapadiaSALE CHIEF FINANCIAL OFFICER $139K
3,746 sh × $37.15
Exec Jan 26
Filed Jan 28 · 5:30 PM ET Sandip KapadiaSALE CHIEF FINANCIAL OFFICER $753K
20,961 sh × $35.92
Exec Jan 15
Filed Jan 20 · 5:30 PM ET Jeffrey M. DaynoSALE PRESIDENT, CEO $1.0M
25,933 sh across 2 lots
Exec Dec 12 2025
Filed Dec 17 2025 · 5:30 PM ET † Sandip KapadiaSALE CHIEF FINANCIAL OFFICER $791K
20,000 sh × $39.54
Exec Dec 5 2025
Filed Dec 9 2025 · 5:30 PM ET Sandip KapadiaSALE CHIEF FINANCIAL OFFICER $120K
3,427 sh × $35.00
Exec Nov 21 2025
Filed Nov 25 2025 · 5:30 PM ET Sandip KapadiaSALE CHIEF FINANCIAL OFFICER $787K
21,573 sh × $36.50
Exec Aug 15 2025
Filed Aug 19 2025 · 5:30 PM ET Sandip KapadiaSALE CHIEF FINANCIAL OFFICER $203K
6,247 sh × $32.48
Exec Apr 1 2025
Filed Apr 3 2025 · 5:30 PM ET Jeffrey DierksSALE CHIEF COMMERCIAL OFFICER $142K
4,369 sh × $32.61
Exec Mar 3 2025
Filed Mar 5 2025 · 5:30 PM ET Jeffrey DierksSALE CHIEF COMMERCIAL OFFICER $490K
13,125 sh across 2 lots
Exec Jan 24 2025
Filed Jan 28 2025 · 5:30 PM ET Sandip KapadiaSALE CHIEF FINANCIAL OFFICER $1.0M
25,000 sh × $40.18
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET Jeffrey M. DaynoSALE PRESIDENT, CEO $774K
19,293 sh × $40.13
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET Jeffrey DierksSALE CHIEF COMMERCIAL OFFICER $1.1M
29,475 sh × $37.41
Exec Jan 16 2025
Filed Jan 21 2025 · 5:30 PM ET Jeffrey DierksSALE CHIEF COMMERCIAL OFFICER $389K
10,507 sh × $37.01
Exec Jan 15 2025
Filed Jan 16 2025 · 5:30 PM ET Jeffrey DierksSALE CHIEF COMMERCIAL OFFICER $266K
7,180 sh × $37.04
Exec Jan 13 2025
Filed Jan 15 2025 · 5:30 PM ET Marshman Fund Trust IISALE 10% owner $139.4M
4,600,000 sh across 2 lots
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET Juan A. SabaterSALE Director $139.4M
4,600,000 sh across 2 lots
Exec Nov 1 2024
Filed Nov 5 2024 · 5:30 PM ET Jeffrey DierksSALE CHIEF COMMERCIAL OFFICER $870K
21,496 sh × $40.47
Exec Oct 29 2024
Filed Oct 31 2024 · 5:30 PM ET Jeffrey DierksSALE CHIEF COMMERCIAL OFFICER $1.2M
35,652 sh × $35.05
Exec Oct 3 2024
Filed Oct 7 2024 · 5:30 PM ET Jeffrey DierksSALE CHIEF COMMERCIAL OFFICER $1.4M
35,846 sh × $40.03
Exec Sep 30 2024
Filed Oct 1 2024 · 5:30 PM ET